Instrument Inactif

Communiqués Access Pharmaceuticals, Inc. OTC Bulletin Board

Actions

ACCP

US00431M3088

Produits pharmaceutiques

Cours en clôture OTC Bulletin Board
- ^USD	-

14/08	Abeona Therapeutics Inc. : Oppenheimer favorable sur le dossier	ZM
13/08	L'action Abeona Therapeutics chute après des résultats décevants au deuxième trimestre	MT

Communiqués

13/08	Abeona Therapeutics: Q2 Earnings Snapshot	AQ
13/08	Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update	AQ
06/08	Abeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026	AQ
04/08	Abeona Therapeutics(R) Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	AQ
04/08	CMS Grants New Technology Add-On Payment (NTAP) Status for ZEVASKYN®	AQ
03/08	Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	AQ
21/07	Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®	AQ
01/07	Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	AQ
01/06	Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	AQ
26/05	Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences	AQ
13/05	Abeona Therapeutics : Presentation Q1 2026 PDF Q1 2026	PU
13/05	Abeona Therapeutics: Q1 Earnings Snapshot	AQ
13/05	Abeona Therapeutics® Reports First Quarter 2026 Results and Provides Pipeline Update	AQ
11/05	Abeona Therapeutics® Announces Activation of Children's Hospital of Philadelphia as a New Qualified Treatment Center for ZEVASKYN®	AQ
04/05	Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	AQ
04/05	Abeona Therapeutics® Announces Date of First Quarter Financial Results	AQ
01/05	Abeona Therapeutics : reg; Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	PU
07/04	Abeona Therapeutics® Announces Appointment of Keith A. Goldan to its Board of Directors	AQ
06/04	Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	AQ
02/04	Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York	AQ
17/03	Abeona Therapeutics: Q4 Earnings Snapshot	AQ
17/03	Abeona Therapeutics® Reports Full Year 2025 Financial Results and Corporate Updates	AQ
09/03	Abeona Therapeutics® Provides Business Update Highlighting Building Momentum in ZEVASKYN® Commercial Launch	AQ
04/03	Abeona Therapeutics Announces Date of Fourth Quarter, Full Year 2025 Financial Results and Participation in Upcoming 2026 Leerink Global Healthcare Conference	AQ
03/03	Abeona Therapeutics® Announces Date of Fourth Quarter / Full Year 2025 Financial Results and Participation in Upcoming 2026 Leerink Global Healthcare Conference	AQ